All Stories

  1. Mortality in Patients With Primary Aldosteronism: A Swedish Nationwide Study

    Article • Hypertension, October 2023, Wolters Kluwer Health

    Professor Gudmundur Johannsson

  2. Increased risk of hospitalization, intensive care and death due to COVID‐19 in patients with adrenal insufficiency: A Swedish nationwide study

    Article • Journal of Internal Medicine, October 2023, Wiley

    Professor Gudmundur Johannsson

  3. Intermittent High-Dose Glucocorticoid Treatment Does Not Cause Adrenal Insufficiency in Patients with Diffuse Large B-Cell Lymphoma: A Prospective Study

    Article • Acta Haematologica, September 2023, Karger Publishers

    Professor Gudmundur Johannsson

  4. Hypotension during transsphenoidal pituitary surgery associated with increase in plasma levels of brain injury markers

    Article • Acta Anaesthesiologica Scandinavica, August 2023, Wiley

    Professor Gudmundur Johannsson

  5. Relation between HLA and copy number variation of steroid 21-hydroxylase in a Swedish cohort of patients with autoimmune Addison's disease

    Article • European Journal of Endocrinology, August 2023, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  6. Glucocorticoids, Cystatin C, and Immunotherapy Failure

    Article • Cell Genomics, August 2023, Elsevier

    Professor Gudmundur Johannsson

  7. Healthcare cost and survival in patients with non-functioning pituitary adenoma

    Article • European Journal of Endocrinology, May 2023, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  8. Diagnosis and testing for growth hormone deficiency across the ages: a global view of the accuracy, caveats, and cut-offs for diagnosis

    Article • Endocrine Connections, April 2023, Bioscientifica

    Professor Gudmundur Johannsson

  9. Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency

    Article • Pituitary, November 2022, Springer Science + Business Media

    Professor Gudmundur Johannsson

  10. Effect of Diabetes on Morbidity and Mortality in Patients With Acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2022, Endocrine Society

    Professor Gudmundur Johannsson

  11. Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer

    Article • Nature Reviews Endocrinology, June 2022, Springer Science + Business Media

    Professor Gudmundur Johannsson

  12. Dose–exposure–IGF-I response of once-weekly somapacitan in adults with GH deficiency

    Article • European Journal of Endocrinology, May 2022, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  13. Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2022, Endocrine Society

    Professor Gudmundur Johannsson

  14. Clinical Biology of the Pituitary Adenoma

    Article • Endocrine Reviews, April 2022, Endocrine Society

    Professor Gudmundur Johannsson

  15. Long-term Safety of Growth Hormone in Adults With Growth Hormone Deficiency: Overview of 15 809 GH-Treated Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2022, Endocrine Society

    Professor Gudmundur Johannsson

  16. Should patients with adult GH deficiency receive GH replacement?

    Article • European Journal of Endocrinology, January 2022, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  17. Incidence of Benign and Malignant Tumors in Patients With Acromegaly Is Increased: A Nationwide Population-based Study

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2021, Endocrine Society

    Professor Gudmundur Johannsson

  18. Safety of growth hormone (GH) treatment in GH deficient children and adults treated for cancer and non-malignant intracranial tumors—a review of research and clinical practice

    Article • Pituitary, July 2021, Springer Science + Business Media

    Professor Gudmundur Johannsson

  19. GH deficiency and insensitivity in children and adults

    Article • Reviews in Endocrine and Metabolic Disorders, February 2021, Springer Science + Business Media

    Professor Gudmundur Johannsson

  20. Endocrinological diagnosis and replacement therapy for hypopituitarism

    Article • January 2021, Elsevier

    Professor Gudmundur Johannsson

  21. Metabolic Effects of Cortisone Acetate vs Hydrocortisone in Patients With Secondary Adrenal Insufficiency

    Article • Journal of the Endocrine Society, October 2020, Endocrine Society

    Professor Gudmundur Johannsson

  22. Body Composition and Bone Mineral Density in Craniopharyngioma Patients: A Longitudinal Study Over 10 Years

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2020, Endocrine Society

    Professor Gudmundur Johannsson

  23. Extended Support Within a Person-Centered Practice After Surgery for Patients With Pituitary Tumors: Protocol for a Quasiexperimental Study

    Article • JMIR Research Protocols, July 2020, JMIR Publications Inc.

    Professor Gudmundur Johannsson

  24. Once-weekly Somapacitan is Effective and Well Tolerated in Adults with GH Deficiency: A Randomized Phase 3 Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2020, Endocrine Society

    Professor Gudmundur Johannsson

  25. Extended Support Within a Person-Centered Practice After Surgery for Patients With Pituitary Tumors: Protocol for a Quasiexperimental Study (Preprint)

    Article • January 2020, JMIR Publications Inc.

    Professor Gudmundur Johannsson

  26. GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid Replacement

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2019, Endocrine Society

    Professor Gudmundur Johannsson

  27. Serum cortisol and vitamin D status are independently associated with blood pressure in pregnancy

    Article • The Journal of Steroid Biochemistry and Molecular Biology, May 2019, Elsevier

    Professor Gudmundur Johannsson

  28. Personalized approach to growth hormone replacement in adults

    Article • Archives of Endocrinology and Metabolism, January 2019, Archives of Endocrinology and Metabolism

    Professor Gudmundur Johannsson

  29. Early Clinical Indicators of Addison Disease in Adults With Type 1 Diabetes: A Nationwide, Observational, Cohort Study

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2018, Endocrine Society

    Professor Gudmundur Johannsson

  30. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement

    Article • European Journal of Endocrinology, October 2018, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  31. Biomarkers of GH action in children and adults

    Article • Growth Hormone & IGF Research, June 2018, Elsevier

    Professor Gudmundur Johannsson

  32. Prevalence and treatment of central hypogonadism and hypoandrogenism in women with hypopituitarism

    Article • Pituitary, May 2018, Springer Science + Business Media

    Professor Gudmundur Johannsson

  33. Adrenal venous sampling: the learning curve of a single interventionalist with 282 consecutive procedures

    Article • Diagnostic and Interventional Radiology, May 2018, Journal of Clinical Research of Pediatric Endocrinology

    Professor Gudmundur Johannsson

  34. Worse Health-Related Quality of Life at long-term follow-up in patients with Cushing's disease than patients with cortisol producing adenoma. Data from the ERCUSYN

    Article • Clinical Endocrinology, April 2018, Wiley

    Oskar Ragnarsson, Professor Gudmundur Johannsson, DAVIDE CARVALHO

  35. Safety and convenience of once-weekly somapacitan in adult GH deficiency: a 26-week randomized, controlled trial

    Article • European Journal of Endocrinology, March 2018, Bioscientifica

    Professor Gudmundur Johannsson

  36. Turning back the clock on adrenal insufficiency

    Article • The Lancet Diabetes & Endocrinology, March 2018, Elsevier

    Professor Gudmundur Johannsson

  37. Multi-centre phase IV trial to investigate the immunogenicity of a new liquid formulation of recombinant human growth hormone in adults with growth hormone deficiency

    Article • Journal of Endocrinological Investigation, February 2018, Springer Science + Business Media

    Professor Gudmundur Johannsson

  38. Growth Hormone Research Society perspective on biomarkers of GH action in children and adults

    Article • Endocrine Connections, February 2018, Bioscientifica

    Professor Jens Otto Lunde Jorgensen, Professor Gudmundur Johannsson

  39. Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study

    Article • European Journal of Endocrinology, February 2018, Bioscientifica

    Professor Gudmundur Johannsson

  40. Primary aldosteronism and thyroid disorders in atrial fibrillation: A Swedish nationwide case–control study

    Article • European Journal of Preventive Cardiology, February 2018, SAGE Publications

    Georgios Mourtzinis, Professor Gudmundur Johannsson

  41. Preoperative medical treatment in Cushing’s syndrome: frequency of use and its impact on postoperative assessment: data from ERCUSYN

    Article • European Journal of Endocrinology, February 2018, Bioscientifica

    Professor Gudmundur Johannsson, DAVIDE CARVALHO

  42. Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016

    Article • European Journal of Endocrinology, January 2018, Bioscientifica

    Professor Gerald Raverot, Professor Gudmundur Johannsson

  43. Primary Adrenal Insufficiency: Managing Mineralocorticoid Replacement Therapy

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2017, Endocrine Society

    Professor Gudmundur Johannsson

  44. Incidence, prevalence and seasonal onset variation of Addison’s disease among persons with type 1 diabetes mellitus: nationwide, matched cohort studies

    Article • European Journal of Endocrinology, October 2017, Bioscientifica

    Dimitrios Chantzichristos, Professor Gudmundur Johannsson

  45. Cytokine Autoantibody Screening in the Swedish Addison Registry Identifies Patients With Undiagnosed APS1

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2017, Endocrine Society

    Professor Gudmundur Johannsson

  46. Excess morbidity and mortality in patients with craniopharyngioma: a hospital-based retrospective cohort study

    Article • European Journal of Endocrinology, October 2017, Bioscientifica

    Mr Mark Wijnen, JAMJL Janssen, Professor Gudmundur Johannsson

  47. The impact of adjustments to the diagnostic criteria for biochemical remission in surgically treated patients with acromegaly

    Article • Growth Hormone & IGF Research, October 2017, Elsevier

    Professor Gudmundur Johannsson

  48. Screening for primary aldosteronism

    Article • Hormone and Metabolic Research, September 2017, Thieme Publishing Group

    Georgios Mourtzinis, Professor Gudmundur Johannsson

  49. Novel biomarkers of cardiovascular disease in patients with Addison's disease

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2017, Endocrine Society

    Professor Gudmundur Johannsson, Dr Ian Louis Ross, Oskar Ragnarsson

  50. MECHANISMS IN ENDOCRINOLOGY: Clinical and pharmacogenetic aspects of the growth hormone receptor polymorphism

    Article • European Journal of Endocrinology, September 2017, Bioscientifica

    PROF CESAR L BOGUSZEWSKI, Professor Gudmundur Johannsson

  51. The metabolic syndrome and its components in 178 patients treated for craniopharyngioma after 16 years of follow-up

    Article • European Journal of Endocrinology, September 2017, Bioscientifica

    Mr Mark Wijnen, JAMJL Janssen, Professor Gudmundur Johannsson

  52. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

    Article • Pituitary, September 2017, Springer Science + Business Media

    Professor Gerald Raverot, Professor Gudmundur Johannsson

  53. Decreased prefrontal functional brain response during memory testing in women with Cushing’s syndrome in remission

    Article • Psychoneuroendocrinology, August 2017, Elsevier

    Professor Gudmundur Johannsson

  54. A polymorphism in the CYP17A1 gene influences the therapeutic response to steroidogenesis inhibitors in Cushing's syndrome

    Article • Clinical Endocrinology, July 2017, Wiley

    Oskar Ragnarsson, Professor Gudmundur Johannsson

  55. Pseudoacromegaly: A Differential Diagnostic Problem for Acromegaly With a Genetic Solution

    Article • Journal of the Endocrine Society, July 2017, Endocrine Society

    Dr Per M Dahlqvist, Professor Gudmundur Johannsson

  56. Prevalence of primary aldosteronism among patients with type 2 diabetes

    Article • Clinical Endocrinology, June 2017, Wiley

    Mauro Tancredi, Professor Gudmundur Johannsson

  57. Higher glucocorticoid replacement doses are associated with increased mortality in patients with pituitary adenoma

    Article • European Journal of Endocrinology, June 2017, Bioscientifica

    Professor Gudmundur Johannsson

  58. Muscle strength in patients with acromegaly at diagnosis and during long-term follow-up

    Article • European Journal of Endocrinology, May 2017, Bioscientifica

    Professor Gudmundur Johannsson

  59. Health Care Burden in Patients With Adrenal Insufficiency

    Article • Journal of the Endocrine Society, April 2017, Endocrine Society

    Professor Gudmundur Johannsson, Claudio Marelli

  60. Diagnostic tests for Cushing's syndrome differ from published guidelines: data from ERCUSYN

    Article • European Journal of Endocrinology, April 2017, Bioscientifica

    Professor Gudmundur Johannsson, DAVIDE CARVALHO

  61. Reduced DNA methylation and psychopathology following endogenous hypercortisolism – a genome-wide study

    Article • Scientific Reports, March 2017, Springer Science + Business Media

    Professor Gudmundur Johannsson

  62. Safety of glucocorticoid replacement in patients with Addison's disease

    Article • European Journal of Endocrinology, March 2017, Bioscientifica

    Professor Gudmundur Johannsson

  63. Incidence of malignant tumours in patients with a non-functioning pituitary adenoma

    Article • Endocrine Related Cancer, March 2017, Bioscientifica

    Professor Gudmundur Johannsson

  64. Life expectancy in patients with pituitary adenoma receiving growth hormone replacement

    Article • European Journal of Endocrinology, January 2017, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  65. Exploring Inpatient Hospitalizations and Morbidity in Patients With Adrenal Insufficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2016, Endocrine Society

    Professor Gudmundur Johannsson

  66. Addison's disease in Sweden

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2016, Endocrine Society

    Professor Gudmundur Johannsson, Dr Per M Dahlqvist, Karel Duchen, Jan Gustafsson

  67. Comorbidities, treatment patterns and cost-of-illness of acromegaly in Sweden: a register-linkage population-based study

    Article • European Journal of Endocrinology, November 2016, Bioscientifica

    Professor Gudmundur Johannsson

  68. Mortality in persons with diabetes mellitus and Addison’s disease

    Article • European Journal of Endocrinology, November 2016, Bioscientifica

    Dimitrios Chantzichristos, Professor Gudmundur Johannsson

  69. Salivary Cortisol and Cortisone do not Appear to be Useful Biomarkers for Monitoring Hydrocortisone Replacement in Addison’s Disease

    Article • Hormone and Metabolic Research, November 2016, Thieme Publishing Group

    Professor Gudmundur Johannsson

  70. Bridging the gap: metabolic and endocrine care of patients during transition

    Article • Endocrine Connections, November 2016, Bioscientifica

    Professor Gudmundur Johannsson

  71. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency

    Article • European Journal of Endocrinology, November 2016, Bioscientifica

    Professor Gudmundur Johannsson

  72. Efficacy and safety of bariatric surgery for craniopharyngioma-related hypothalamic obesity: a matched case–control study with 2 years of follow-up

    Article • International Journal of Obesity, October 2016, Nature

    Mr Mark Wijnen, JAMJL Janssen, Professor Gudmundur Johannsson

  73. Diagnosing and Treating the Syndrome of Inappropriate Antidiuretic Hormone Secretion

    Article • The American Journal of Medicine, May 2016, Elsevier

    Professor Gudmundur Johannsson

  74. Achieving a physiological cortisol profile with once-daily dual-release hydrocortisone: a pharmacokinetic study

    Article • European Journal of Endocrinology, April 2016, Bioscientifica

    Professor Gudmundur Johannsson

  75. Editorial discussion new options for glucocorticoid replacement therapy

    Article • Endocrine, April 2016, Springer Science + Business Media

    Professor Gudmundur Johannsson

  76. Growth Hormone Research Society perspective on the development of long-acting growth hormone preparations: Table 1

    Article • European Journal of Endocrinology, March 2016, Bioscientifica

    Professor Gudmundur Johannsson

  77. Hypopituitarism

    Article • The Lancet, March 2016, Elsevier

    Professor Gudmundur Johannsson

  78. The cardiovascular risk reduction benefits of a low-carbohydrate diet outweigh the potential increase in LDL-cholesterol

    Article • British Journal Of Nutrition, February 2016, Cambridge University Press

    Dr Thomas R Wood, Professor Gudmundur Johannsson

  79. Proposal of a clinical response score and predictors of clinical response to 2 years of GH replacement therapy in adult GH deficiency

    Article • European Journal of Endocrinology, September 2015, Bioscientifica

    Professor Gudmundur Johannsson

  80. Estimation of body fluids with bioimpedance spectroscopy: state of the art methods and proposal of novel methods

    Article • Physiological Measurement, September 2015, Institute of Physics Publishing

    Professor Gudmundur Johannsson

  81. Slightly superior performance of bioimpedance spectroscopy over single frequency regression equations for assessment of total body water

    Article • August 2015, Institute of Electrical & Electronics Engineers (IEEE)

    Professor Gudmundur Johannsson

  82. Reviewing the safety of GH replacement therapy in adults

    Article • Growth Hormone & IGF Research, August 2015, Elsevier

    Professor Gudmundur Johannsson

  83. Excess Mortality in Women and Young Adults With Nonfunctioning Pituitary Adenoma: A Swedish Nationwide Study

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2015, Endocrine Society

    Professor Gudmundur Johannsson

  84. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children

    Article • Growth Hormone & IGF Research, June 2015, Elsevier

    Professor Gudmundur Johannsson

  85. Long-Term Outcome and MGMT as a Predictive Marker in 24 Patients With Atypical Pituitary Adenomas and Pituitary Carcinomas Given Treatment With Temozolomide

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2015, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Daniel Bengtsson

  86. MECHANISMS IN ENDOCRINOLOGY: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies

    Article • February 2015, Bioscientifica

    Professor Gudmundur Johannsson

  87. The GH receptor exon 3 deleted/full-length polymorphism is associated with central adiposity in the general population

    Article • European Journal of Endocrinology, February 2015, Bioscientifica

    Professor Gudmundur Johannsson

  88. GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults

    Article • February 2015, Bioscientifica

    Professor Peter E Clayton, Professor Gudmundur Johannsson

  89. Excess Mortality and Morbidity in Patients with Craniopharyngioma, Especially in Patients with Childhood Onset: A Population-Based Study in Sweden

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2015, Endocrine Society

    Professor Gudmundur Johannsson

  90. Systematic review of surgery and outcomes in patients with primary aldosteronism

    Article • British Journal of Surgery, January 2015, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  91. Mean Expected Error in Prediction of Total Body Water: A True Accuracy Comparison between Bioimpedance Spectroscopy and Single Frequency Regression Equations

    Article • BioMed Research International, January 2015, Hindawi Publishing Corporation

    Professor Gudmundur Johannsson

  92. Body composition and bone mineral density in women with Cushing's syndrome in remission and the association with common genetic variants influencing glucocorticoid sensitivity

    Article • November 2014, Bioscientifica

    Professor Gudmundur Johannsson, Oskar Ragnarsson

  93. The relationship between glucocorticoid replacement and quality of life in 2737 hypopituitary patients

    Article • European Journal of Endocrinology, November 2014, Bioscientifica

    Professor Gudmundur Johannsson, Oskar Ragnarsson

  94. Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy

    Article • Clinical Endocrinology, October 2014, Wiley

    Professor Gudmundur Johannsson

  95. Common Genetic Variants in the Glucocorticoid Receptor and the 11β-Hydroxysteroid Dehydrogenase Type 1 Genes Influence Long-Term Cognitive Impairments in Patients With Cushing's Syndrome in Remission

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2014, Endocrine Society

    Professor Gudmundur Johannsson

  96. Extracellular Water and Blood Pressure in Adults with Growth Hormone (GH) Deficiency: A Genotype-Phenotype Association Study

    Article • PLoS ONE, August 2014, PLOS

    Professor Gudmundur Johannsson, PROF CESAR L BOGUSZEWSKI

  97. Safety of glucocorticoid replacement

    Article • June 2014, Bioscientifica

    Professor Gudmundur Johannsson

  98. Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments

    Article • Current Medical Research and Opinion, June 2014, Informa Healthcare

    Professor Gudmundur Johannsson

  99. Effects of Long-term Growth Hormone Replacement in Adults With Growth Hormone Deficiency Following Cure of Acromegaly: A KIMS Analysis

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2014, Endocrine Society

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson, Marta Korbonits

  100. Robustness study of the different immittance spectra and frequency ranges in bioimpedance spectroscopy analysis for assessment of total body composition

    Article • Physiological Measurement, May 2014, Institute of Physics Publishing

    Professor Gudmundur Johannsson

  101. The Impact of Glucocorticoid Replacement on Bone Mineral Density in Patients With Hypopituitarism Before and After 2 Years of Growth Hormone Replacement Therapy

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2014, Endocrine Society

    Professor Gudmundur Johannsson

  102. Replacement therapy in adult hypopituitarism

    Article • March 2014, Taylor & Francis

    Professor Gudmundur Johannsson

  103. Replacement therapy in adult hypopituitarism

    Article • March 2014, Taylor & Francis

    Professor Gudmundur Johannsson

  104. Cardiovascular Risk Factors in Patients with Addison's Disease: A Comparative Study of South African and Swedish Patients

    Article • PLoS ONE, March 2014, PLOS

    Professor Gudmundur Johannsson

  105. Saving lives of patients with adrenal insufficiency: a pan‐European initiative?

    Article • Clinical Endocrinology, January 2014, Wiley

    Professor Gudmundur Johannsson

  106. Cardiovascular and Metabolic Impact of Glucocorticoid Replacement Therapy

    Article • January 2014, Karger Publishers

    Professor Gudmundur Johannsson

  107. Baseline characteristics and effects of ten years of growth hormone (GH) replacement therapy in adults previously treated with pituitary irradiation

    Article • Growth Hormone & IGF Research, December 2013, Elsevier

    Professor Gudmundur Johannsson

  108. SNPs within the GH-signaling pathway are associated with the early IGF1 response to GH replacement therapy in GHD adults

    Article • October 2013, Bioscientifica

    Professor Gudmundur Johannsson

  109. THERAPY OF ENDOCRINE DISEASE: Perspectives on the management of adrenal insufficiency: clinical insights from across Europe

    Article • September 2013, Bioscientifica

    Professor Gudmundur Johannsson, ashley grossman

  110. MANAGEMENT OF ENDOCRINE DISEASE: Cushing's syndrome: a structured short- and long-term management plan for patients in remission

    Article • August 2013, Bioscientifica

    Professor Gudmundur Johannsson, Oskar Ragnarsson

  111. Inadequate testosterone suppression after medical and subsequent surgical castration in a patient with prostate cancer

    Article • BMJ Case Reports, August 2013, BMJ

    Professor Gudmundur Johannsson

  112. Increased Cardiovascular Risk in South African Patients with Addison’s Disease

    Article • Hormone and Metabolic Research, August 2013, Thieme Publishing Group

    Dr Ian Louis Ross, Professor Gudmundur Johannsson

  113. Neurodegenerative and inflammatory biomarkers in cerebrospinal fluid in patients with Cushing's syndrome in remission

    Article • June 2013, Bioscientifica

    Professor Gudmundur Johannsson, Oskar Ragnarsson

  114. Growth Hormone Research Society Workshop Summary: Consensus Guidelines for Recombinant Human Growth Hormone Therapy in Prader-Willi Syndrome

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2013, Endocrine Society

    Professor Gudmundur Johannsson

  115. Psychosocial health and levels of employment in 851 hypopituitary Swedish patients on long-term GH therapy

    Article • Psychoneuroendocrinology, June 2013, Elsevier

    Professor Gudmundur Johannsson

  116. Ethnicity influences the diagnosis of primary adrenal insufficiency

    Article • Clinical Endocrinology, April 2013, Wiley

    Professor Gudmundur Johannsson

  117. The GH/IGF-1 axis in obesity: pathophysiology and therapeutic considerations

    Article • Nature Reviews Endocrinology, April 2013, Nature

    Professor Gudmundur Johannsson

  118. Deaths Among Adult Patients With Hypopituitarism: Hypocortisolism During Acute Stress, and De Novo Malignant Brain Tumors Contribute to an Increased Mortality

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2013, Endocrine Society

    Professor Gudmundur Johannsson

  119. Acupuncture for ovulation induction in polycystic ovary syndrome: a randomized controlled trial

    Article • AJP Endocrinology and Metabolism, March 2013, American Physiological Society

    Professor Gudmundur Johannsson

  120. Fifteen years of GH replacement improves body composition and cardiovascular risk factors

    Article • February 2013, Bioscientifica

    Professor Gudmundur Johannsson

  121. Investigation of glucocorticoid receptor polymorphisms in relation to metabolic parameters in Addison's disease

    Article • December 2012, Bioscientifica

    Professor Gudmundur Johannsson

  122. Effect of short-term GH and testosterone administration on body composition and glucose homoeostasis in men receiving chronic glucocorticoid therapy

    Article • November 2012, Bioscientifica

    Professor Gudmundur Johannsson, Oskar Ragnarsson

  123. Unilateral adrenal hyperplasia is a usual cause of primary hyperaldosteronism. Results from a Swedish screening study

    Article • BMC Endocrine Disorders, September 2012, Springer Science + Business Media

    Professor Gudmundur Johannsson

  124. Long-Term Cognitive Impairments and Attentional Deficits in Patients with Cushing's Disease and Cortisol-Producing Adrenal Adenoma in Remission

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2012, Endocrine Society

    Professor Gudmundur Johannsson

  125. Discontinuing Long-Term GH Replacement Therapy—A Randomized, Placebo-Controlled Crossover Trial in Adult GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2012, Endocrine Society

    Professor Gudmundur Johannsson

  126. Salivary Cortisol Day Curves in Addison’s Disease in Patients on Hydrocortisone Replacement

    Article • Hormone and Metabolic Research, August 2012, Thieme Publishing Group

    Dr Ian Louis Ross, Professor Gudmundur Johannsson

  127. A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12...

    Article • The Aging Male, July 2012, Taylor & Francis

    Professor Gudmundur Johannsson

  128. Genotypes associated with lipid metabolism contribute to differences in serum lipid profile of GH-deficient adults before and after GH replacement therapy

    Article • June 2012, Bioscientifica

    Edna Barbosa, Professor Gudmundur Johannsson

  129. Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency - a worldwide patient survey

    Article • BMC Endocrine Disorders, June 2012, Springer Science + Business Media

    Professor Gudmundur Johannsson

  130. Tumour recurrence and enlargement in patients with craniopharyngioma with and without GH replacement therapy during more than 10 years of follow-up

    Article • March 2012, Bioscientifica

    Professor Gudmundur Johannsson

  131. Differential Effects of Raloxifene and Estrogen on Body Composition in Growth Hormone-Replaced Hypopituitary Women

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2012, Endocrine Society

    Dr Nicola Armstrong, Professor Gudmundur Johannsson

  132. 2 Differential diagnosis of hyponatraemia

    Article • Best Practice & Research Clinical Endocrinology & Metabolism, March 2012, Elsevier

    Professor Gudmundur Johannsson

  133. Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency

    Article • February 2012, Bioscientifica

    Professor Gudmundur Johannsson

  134. Improved Cortisol Exposure-Time Profile and Outcome in Patients with Adrenal Insufficiency: A Prospective Randomized Trial of a Novel Hydrocortisone Dual-Release Formulation

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2012, Endocrine Society

    Professor Gudmundur Johannsson

  135. Comorbidity and cardiovascular risk factors in adult GH deficiency following treatment for Cushing's disease or non-functioning pituitary adenomas during childhood

    Article • January 2012, Bioscientifica

    Professor Ulla Feldt-Rasmussen, Oskar Ragnarsson, Professor Gudmundur Johannsson

  136. Glucocorticoid replacement therapy is independently associated with reduced bone mineral density in women with hypopituitarism

    Article • Clinical Endocrinology, January 2012, Wiley

    Professor Gudmundur Johannsson

  137. Hippocampal volumes in patients exposed to low-dose radiation to the basal brain. A case–control study in long-term survivors from cancer in the head and neck region

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Professor Gudmundur Johannsson

  138. Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region

    Article • Radiation Oncology, January 2012, Springer Science + Business Media

    Professor Gudmundur Johannsson

  139. Effects of 3-year GH replacement therapy on bone mineral density in younger and elderly adults with adult-onset GH deficiency

    Article • November 2011, Bioscientifica

    Professor Gudmundur Johannsson

  140. The metabolic consequences of thyroxine replacement in adult hypopituitary patients

    Article • Pituitary, October 2011, Springer Science + Business Media

    Professor Ulla Feldt-Rasmussen, Professor Gudmundur Johannsson

  141. Long-Acting Growth Hormone for Replacement Therapy

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2011, Endocrine Society

    Professor Gudmundur Johannsson

  142. Tumor Recurrence and Enlargement in Patients with Craniopharyngioma with and without Growth Hormone Replacement Therapy during More Than 10 Years of Follow-Up

    Article • June 2011, Endocrine Society

    Professor Gudmundur Johannsson

  143. Detection of genetic hypopituitarism in an adult population of idiopathic pituitary insufficiency patients with growth hormone deficiency

    Article • Pituitary, December 2010, Springer Science + Business Media

    Dr Alexandru SAVEANU, Professor Gudmundur Johannsson

  144. Muscle strength in elderly adults with GH deficiency after 10 years of GH replacement

    Article • European Journal of Endocrinology, August 2010, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  145. Rapid and high throughput genotyping of the growth hormone receptor exon 3 deleted/full-length polymorphism using a tagSNP

    Article • Growth Hormone & IGF Research, June 2010, Elsevier

    Professor Gudmundur Johannsson

  146. Modulatory Effect of Raloxifene and Estrogen on the Metabolic Action of Growth Hormone in Hypopituitary Women

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2010, Endocrine Society

    Professor Gudmundur Johannsson

  147. Models to predict changes in serum IGF1 and body composition in response to GH replacement therapy in GH-deficient adults

    Article • European Journal of Endocrinology, May 2010, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  148. Diagnosis: A reappraisal of the diagnosis of growth hormone deficiency

    Article • Nature Reviews Endocrinology, April 2010, Nature

    Professor Gudmundur Johannsson

  149. Modulatory Effect of Raloxifene and Estrogen on the Metabolic Action of Growth Hormone in Hypopituitary Women

    Article • Molecular Endocrinology, April 2010, Endocrine Society

    Professor Gudmundur Johannsson

  150. Bioelectrical impedance spectroscopy in growth hormone-deficient adults

    Article • Physiological Measurement, November 2009, Institute of Physics Publishing

    Professor Gudmundur Johannsson

  151. Comparing progression of non-functioning pituitary adenomas in hypopituitarism patients with and without long-term GH replacement therapy

    Article • European Journal of Endocrinology, November 2009, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  152. GH replacement in adults: interactions with other pituitary hormone deficiencies and replacement therapies

    Article • European Journal of Endocrinology, November 2009, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  153. Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

    Article • European Journal of Endocrinology, October 2009, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  154. Lack of regulation of 11β-hydroxysteroid dehydrogenase type 1 during short-term manipulation of GH in patients with hypopituitarism

    Article • European Journal of Endocrinology, September 2009, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  155. Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study

    Article • European Journal of Endocrinology, July 2009, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  156. The aging population – Is there a role for endocrine interventions?

    Article • Growth Hormone & IGF Research, April 2009, Elsevier

    Professor Gudmundur Johannsson

  157. The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women

    Article • Growth Hormone & IGF Research, April 2009, Elsevier

    Professor Gudmundur Johannsson

  158. Ten Years of Growth Hormone (GH) Replacement Normalizes Muscle Strength in GH-Deficient Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2009, Endocrine Society

    Professor Gudmundur Johannsson

  159. Influence of the Exon 3-Deleted/Full-Length Growth Hormone (GH) Receptor Polymorphism on the Response to GH Replacement Therapy in Adults with Severe GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, February 2009, Endocrine Society

    PROF CESAR L BOGUSZEWSKI, Professor Gudmundur Johannsson

  160. Treatment of Growth Hormone Deficiency in Adults

    Article • Hormone Research in Paediatrics, January 2009, Karger Publishers

    Professor Gudmundur Johannsson

  161. Role of the GH/IGF-1 axis in lifespan and healthspan: Lessons from animal models

    Article • Growth Hormone & IGF Research, December 2008, Elsevier

    Professor Gudmundur Johannsson

  162. Central Adiposity as an Important Confounder in the Diagnosis of Adult Growth Hormone Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2008, Endocrine Society

    Professor Gudmundur Johannsson

  163. Exploring the use of recombinant human TSH in the diagnosis of central hypothyroidism

    Article • European Journal of Endocrinology, August 2008, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  164. The Prevalence of Celiac Disease in Blood Donors in Iceland

    Article • Digestive Diseases and Sciences, July 2008, Springer Science + Business Media

    Professor Gudmundur Johannsson

  165. Baseline Characteristics and the Effects of Two Years of Growth Hormone (GH) Replacement Therapy in Adults with GH Deficiency Previously Treated for Acromegaly

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2008, Endocrine Society

    Professor Gudmundur Johannsson

  166. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors

    Article • Expert Opinion on Drug Metabolism & Toxicology, June 2008, Taylor & Francis

    Professor Gudmundur Johannsson

  167. Impact of Growth Hormone and Dehydroepiandrosterone on Protein Metabolism in Glucocorticoid-Treated Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2008, Endocrine Society

    Professor Gudmundur Johannsson

  168. Management of growth hormone deficiency in adults

    Article • Growth Hormone & IGF Research, December 2007, Elsevier

    Professor Gudmundur Johannsson

  169. Impact of Acute and Chronic Low-Dose Glucocorticoids on Protein Metabolism

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2007, Endocrine Society

    Professor Gudmundur Johannsson

  170. Nonfatal Stroke, Cardiac Disease, and Diabetes Mellitus in Hypopituitary Patients on Hormone Replacement Including Growth Hormone

    Article • The Journal of Clinical Endocrinology & Metabolism, September 2007, Endocrine Society

    Professor Gudmundur Johannsson

  171. Fracture Incidence in GH-Deficient Patients on Complete Hormone Replacement Including GH

    Article • Journal of Bone and Mineral Research, August 2007, Wiley

    Professor Gudmundur Johannsson

  172. Growth Hormone Reduces Inflammation in Postmenopausal Women with Abdominal Obesity: A 12-Month, Randomized, Placebo-Controlled Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2007, Endocrine Society

    Professor Gudmundur Johannsson

  173. A 10-Year, Prospective Study of the Metabolic Effects of Growth Hormone Replacement in Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2007, Endocrine Society

    Professor Gudmundur Johannsson

  174. Management of Adult Growth Hormone Deficiency

    Article • Endocrinology and Metabolism Clinics of North America, March 2007, Elsevier

    Professor Gudmundur Johannsson

  175. Management of the Child Born Small for Gestational Age through to Adulthood: A Consensus Statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2007, Endocrine Society

    Dr Alan David Rogol, Professor Gudmundur Johannsson

  176. Long-Acting Hydrocortisone for Glucocorticoid Replacement Therapy

    Article • Hormone Research in Paediatrics, January 2007, Karger Publishers

    Professor Gudmundur Johannsson

  177. Ten-year GH replacement increases bone mineral density in hypopituitary patients with adult onset GH deficiency

    Article • European Journal of Endocrinology, January 2007, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  178. Premature Mortality in Patients with Addison’s Disease: A Population-Based Study

    Article • The Journal of Clinical Endocrinology & Metabolism, December 2006, Endocrine Society

    Professor Gudmundur Johannsson

  179. Baseline Characteristics and Effects of Growth Hormone Therapy over Two Years in Younger and Elderly Adults with Adult Onset GH Deficiency

    Article • The Journal of Clinical Endocrinology & Metabolism, November 2006, Endocrine Society

    Professor Gudmundur Johannsson

  180. The Impact of Glucocorticoid Replacement Regimens on Metabolic Outcome and Comorbidity in Hypopituitary Patients

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2006, Endocrine Society

    Professor Gudmundur Johannsson

  181. Baseline characteristics and response to GH replacement of hypopituitary patients previously irradiated for pituitary adenoma or craniopharyngioma: data from the Pfizer International Metabolic Database

    Article • European Journal of Endocrinology, August 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  182. Thigh intermuscular fat is inversely associated with spontaneous GH release in post-menopausal women with abdominal obesity

    Article • European Journal of Endocrinology, August 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  183. Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?

    Article • European Journal of Endocrinology, July 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  184. GH secretory pattern in young adults who discontinued GH treatment for GH deficiency and decreased longitudinal growth in childhood

    Article • European Journal of Endocrinology, July 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  185. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy

    Article • Clinical Endocrinology, June 2006, Wiley

    Professor Gudmundur Johannsson

  186. Body composition during GH replacement in adults – methodological variations with respect to gender

    Article • European Journal of Endocrinology, April 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  187. The GH/IGF-1 Axis in Obesity: Physiological and Pathological Aspects

    Article • Metabolic Syndrome and Related Disorders, March 2006, Mary Ann Liebert Inc

    Professor Gudmundur Johannsson

  188. Regulating of Growth Hormone Sensitivity by Sex Steroids: Implications for Therapy

    Article • January 2006, Karger Publishers

    Professor Gudmundur Johannsson

  189. The liquorice effect on the RAAS differs between the genders

    Article • Blood Pressure, January 2006, Taylor & Francis

    Professor Gudmundur Johannsson

  190. Liquorice in Moderate Doses Does Not Affect Sex Steroid Hormones of Biological Importance although the Effect Differs between the Genders

    Article • Hormone Research in Paediatrics, January 2006, Karger Publishers

    Professor Gudmundur Johannsson

  191. GH effect on enzyme activity of 11βHSD in abdominal obesity is dependent on treatment duration

    Article • European Journal of Endocrinology, January 2006, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  192. Growth hormone and testosterone interact positively to enhance protein and energy metabolism in hypopituitary men

    Article • AJP Endocrinology and Metabolism, August 2005, American Physiological Society

    Professor Gudmundur Johannsson

  193. Independent and Combined Effects of Testosterone and Growth Hormone on Extracellular Water in Hypopituitary Men

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2005, Endocrine Society

    Professor Gudmundur Johannsson

  194. Comparison of the Metabolic Effects of Raloxifene and Oral Estrogen in Postmenopausal and Growth Hormone-Deficient Women

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2005, Endocrine Society

    Professor Gudmundur Johannsson

  195. Body composition in young adult survivors of childhood acute lymphoblastic leukaemia

    Article • European Journal of Endocrinology, July 2005, Oxford University Press (OUP)

    Professor Gudmundur Johannsson

  196. Adiponectin, Leptin, and Erythrocyte Sodium/Lithium Countertransport Activity, But Not Resistin, Are Related to Glucose Metabolism in Growth Hormone-Deficient Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2005, Endocrine Society

    Professor Gudmundur Johannsson

  197. Growth Hormone Treatment Reduces Abdominal Visceral Fat in Postmenopausal Women with Abdominal Obesity: A 12-Month Placebo-Controlled Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2005, Endocrine Society

    Professor Gudmundur Johannsson

  198. Clinical Monitoring of Growth Hormone Replacement in Adults

    Article • January 2005, Karger Publishers

    Professor Gudmundur Johannsson

  199. The effects of five-year growth hormone replacement therapy on muscle strength in elderly hypopituitary patients

    Article • Clinical Endocrinology, January 2005, Wiley

    Professor Gudmundur Johannsson

  200. Estrogen Regulation of Growth Hormone Action

    Article • Endocrine Reviews, October 2004, Endocrine Society

    Professor Gudmundur Johannsson

  201. Safety of growth hormone replacement therapy in adults

    Article • Expert Opinion on Drug Safety, July 2004, Informa Healthcare

    Professor Gudmundur Johannsson

  202. Malignant Disease and Cardiovascular Morbidity in Hypopituitary Adults with or without Growth Hormone Replacement Therapy

    Article • The Journal of Clinical Endocrinology & Metabolism, July 2004, Endocrine Society

    Professor Gudmundur Johannsson

  203. Low birth size and final height predict high sympathetic nerve activity in adulthood

    Article • Journal of Hypertension, June 2004, Wolters Kluwer Health

    Professor Gudmundur Johannsson

  204. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption

    Article • Growth Hormone & IGF Research, June 2004, Elsevier

    Professor Gudmundur Johannsson

  205. Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease

    Article • Clinical Endocrinology, May 2004, Wiley

    Professor Gudmundur Johannsson

  206. Long-Term Monitoring of Insulin-Like Growth Factor I in Adult Growth Hormone Deficiency: A Critical Appraisal

    Article • Hormone Research in Paediatrics, January 2004, Karger Publishers

    Professor Gudmundur Johannsson

  207. Growth hormone (GH) replacement in GH-deficient adults: a crossover trial comparing the effect on metabolic control, well-being and compliance of three injections per week versus daily injections

    Article • Growth Hormone & IGF Research, December 2003, Elsevier

    Professor Gudmundur Johannsson

  208. The effect of growth hormone (GH) replacement therapy on sympathetic nerve hyperactivity in hypopituitary adults

    Article • Journal of Hypertension, October 2003, Wolters Kluwer Health

    Professor Gudmundur Johannsson

  209. Effects of GH and insulin-like growth factor-I on body composition

    Article • Journal of Endocrinological Investigation, September 2003, Springer Science + Business Media

    Professor Gudmundur Johannsson

  210. End-stage renal disease: endocrine aspects of treatment

    Article • Growth Hormone & IGF Research, August 2003, Elsevier

    Professor Gudmundur Johannsson

  211. Increased Interleukin-6 levels in pituitary-deficient patients are independently related to their carotid intima-media thickness

    Article • Clinical Endocrinology, July 2003, Wiley

    Professor Gudmundur Johannsson

  212. Five Years of Growth Hormone Replacement Therapy in Adults: Age- and Gender-Related Changes in Isometric and Isokinetic Muscle Strength

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2003, Endocrine Society

    Professor Gudmundur Johannsson

  213. Growth Hormone Deficiency: Strategies and Indications to Continue Growth Hormone Therapy in Transition from Adolescence to Adult Life

    Article • Hormone Research in Paediatrics, January 2003, Karger Publishers

    Professor Gudmundur Johannsson

  214. Intima-media thickness in cardiovascularly asymptomatic hypopituitary adults with growth hormone deficiency: relation to body mass index, gender, and other cardiovascular risk factors

    Article • Clinical Endocrinology, December 2002, Wiley

    Professor Gudmundur Johannsson

  215. Growth hormone (GH) replacement therapy in GH-deficient women during pregnancy

    Article • Clinical Endocrinology, August 2002, Wiley

    Professor Gudmundur Johannsson, PROF CESAR L BOGUSZEWSKI

  216. Growth hormone replacement therapy induces codeine clearance

    Article • European Journal of Clinical Investigation, July 2002, Wiley

    Professor Gudmundur Johannsson

  217. Increased Orderliness of Growth Hormone (GH) Secretion in GH-Deficient Adults with Low Serum Insulin-Like Growth Factor I

    Article • The Journal of Clinical Endocrinology & Metabolism, June 2002, Endocrine Society

    Professor Gudmundur Johannsson

  218. Low Dose Dehydroepiandrosterone Affects Behavior in Hypopituitary Androgen-Deficient Women: A Placebo-Controlled Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, May 2002, Endocrine Society

    Professor Gudmundur Johannsson

  219. GH Increases Extracellular Volume by Stimulating Sodium Reabsorption in the Distal Nephron and Preventing Pressure Natriuresis

    Article • The Journal of Clinical Endocrinology & Metabolism, April 2002, Endocrine Society

    Professor Gudmundur Johannsson

  220. Raloxifene Does Not Affect Insulin Sensitivity or Glycemic Control in Postmenopausal Women with Type 2 Diabetes Mellitus: A Randomized Clinical Trial

    Article • The Journal of Clinical Endocrinology & Metabolism, January 2002, Endocrine Society

    Professor Gudmundur Johannsson

  221. Is the somatotropic axis related to sympathetic nerve activity in healthy ageing men?

    Article • Journal of Hypertension, November 2001, Wolters Kluwer Health

    Professor Gudmundur Johannsson

  222. Currently used growth-promoting treatment of children results in normal bone mass and density. A prospective trial of discontinuing growth hormone treatment in adolescents‡

    Article • Clinical Endocrinology, November 2001, Wiley

    Professor Gudmundur Johannsson

  223. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist

    Article • The Lancet, November 2001, Elsevier

    Professor Gudmundur Johannsson

  224. GH Is Needed for the Maturation of Muscle Mass and Strength in Adolescents

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2001, Endocrine Society

    Professor Gudmundur Johannsson

  225. A Prospective Study of 5 Years of GH Replacement Therapy in GH-Deficient Adults: Sustained Effects on Body Composition, Bone Mass, and Metabolic Indices

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2001, Endocrine Society

    Professor Gudmundur Johannsson

  226. Baseline Characteristics and the Effects of Five Years of GH Replacement Therapy in Adults with GH Deficiency of Childhood or Adulthood Onset: A Comparative, Prospective Study

    Article • The Journal of Clinical Endocrinology & Metabolism, October 2001, Endocrine Society

    Professor Gudmundur Johannsson

  227. Commencing growth hormone replacement in adults with a fixed low dose. Effects on serum lipoproteins, glucose metabolism, body composition, and cardiovascular function

    Article • Growth Hormone & IGF Research, October 2001, Elsevier

    Professor Gudmundur Johannsson

  228. A Prospective Investigation of Quality of Life and Psychological Well-Being after the Discontinuation of GH Treatment in Adolescent Patients Who Had GH Deficiency during Childhood

    Article • The Journal of Clinical Endocrinology & Metabolism, August 2001, Endocrine Society

    Professor Gudmundur Johannsson

  229. Visceral obesity and the role of the somatotropic axis in the development of metabolic complications

    Article • Growth Hormone & IGF Research, June 2001, Elsevier

    Professor Gudmundur Johannsson

  230. Safety aspects of growth hormone replacement in adults

    Article • Growth Hormone & IGF Research, April 2001, Elsevier

    Professor Gudmundur Johannsson

  231. Body Composition and Quality of Life as Markers of the Efficacy of Growth Hormone Replacement Therapy in Adults

    Article • Hormone Research in Paediatrics, January 2001, Karger Publishers

    Professor Gudmundur Johannsson

  232. Sympathetic Neural Burst Amplitude Distribution

    Article • Circulation, October 2000, Wolters Kluwer Health

    Professor Gudmundur Johannsson

  233. A nine-month, placebo-controlled study of the effects of growth hormone treatment on lipoproteins and LDL size in abdominally obese men

    Article • Growth Hormone & IGF Research, June 2000, Elsevier

    Professor Gudmundur Johannsson

  234. Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant

    Article • New England Journal of Medicine, April 2000, New England Journal of Medicine (NEJM/MMS)

    Professor Gudmundur Johannsson

  235. Growth hormone and ageing

    Article • Growth Hormone & IGF Research, April 2000, Elsevier

    Professor Gudmundur Johannsson

  236. The Treatment of Growth Hormone Deficiency in Adults

    Article • The Journal of Clinical Endocrinology & Metabolism, March 2000, Endocrine Society

    Professor Gudmundur Johannsson

  237. GH and Bone-Experimental and Clinical Studies

    Article • Endocrine Journal, January 2000, Japan Endocrine Society

    Professor Gudmundur Johannsson

  238. Discontinuation of Growth Hormone (GH) Treatment: Metabolic Effects in GH-Deficient and GH-Sufficient Adolescent Patients Compared with Control Subjects

    Article • The Journal of Clinical Endocrinology & Metabolism, December 1999, Endocrine Society

    Professor Gudmundur Johannsson

  239. Effect of growth-hormone therapy on early atherosclerotic changes in GH-deficient adults

    Article • The Lancet, June 1999, Elsevier

    Professor Gudmundur Johannsson

  240. Treatment of Obese Subjects with the Oral Growth Hormone Secretagogue MK-677 Affects Serum Concentrations of Several Lipoproteins, But Not Lipoprotein(a)

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1999, Endocrine Society

    Professor Gudmundur Johannsson

  241. Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: Anabolic effect and functional improvement

    Article • American Journal of Kidney Diseases, April 1999, Elsevier

    Professor Gudmundur Johannsson

  242. Growth Hormone (GH) Therapy in GH-Deficient Adults Influences the Response to a Dietary Load of Cholesterol and Saturated Fat in Terms of Cholesterol Synthesis, But Not Serum Low Density Lipoprotein Cholesterol Levels

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1999, Endocrine Society

    Professor Gudmundur Johannsson

  243. Effects of GH on Lipid Metabolism

    Article • January 1999, Springer Science + Business Media

    Professor Gudmundur Johannsson

  244. Serum Leptin Concentration and Insulin Sensitivity in Men with Abdominal Obesity

    Article • Obesity Research, November 1998, Wiley

    Professor Gudmundur Johannsson

  245. 3 Growth hormone therapy and fracture risk in the growth hormone-deficient adult

    Article • Baillière s Clinical Endocrinology and Metabolism, July 1998, Elsevier

    Professor Gudmundur Johannsson

  246. Intense Sympathetic Nerve Activity in Adults with Hypopituitarism and Untreated Growth Hormone Deficiency1

    Article • The Journal of Clinical Endocrinology & Metabolism, June 1998, Endocrine Society

    Professor Gudmundur Johannsson

  247. Beneficial effects of long-term GH replacement therapy on quality of life in adults with GH deficiency

    Article • Clinical Endocrinology, May 1998, Wiley

    Professor Gudmundur Johannsson

  248. Foreword

    Article • Growth Hormone & IGF Research, April 1998, Elsevier

    Professor Gudmundur Johannsson

  249. Individualized dose titration of growth hormone (GH) during GH replacement in hypopituitary adults

    Article • Clinical Endocrinology, November 1997, Wiley

    Professor Gudmundur Johannsson

  250. Not Only Growth Hormone (GH)-Deficient Men Are More Responsive to GH Than Women1

    Article • The Journal of Clinical Endocrinology & Metabolism, October 1997, Endocrine Society

    Professor Gudmundur Johannsson

  251. Two Years of Growth Hormone (GH) Treatment Increase Isometric and Isokinetic Muscle Strength in GH-Deficient Adults1

    Article • The Journal of Clinical Endocrinology & Metabolism, September 1997, Endocrine Society

    Professor Gudmundur Johannsson

  252. Insulin‐like growth factor‐I in growth hormone‐deficient adults: relationship to population‐based normal values, body composition and insulin tolerance test

    Article • Clinical Endocrinology, May 1997, Wiley

    Professor Gudmundur Johannsson

  253. Circulating Non-22-Kilodalton Growth Hormone Isoforms in Acromegalic Men before and after Transsphenoidal Surgery1

    Article • The Journal of Clinical Endocrinology & Metabolism, May 1997, Endocrine Society

    Professor Gudmundur Johannsson, PROF CESAR L BOGUSZEWSKI

  254. Growth Hormone Therapy in GH-Deficient Adults: The Problem of the Dose—Authors’ Response1

    Article • The Journal of Clinical Endocrinology & Metabolism, April 1997, Endocrine Society

    Professor Gudmundur Johannsson

  255. Growth Hormone Treatment of Abdominally Obese Men Reduces Abdominal Fat Mass, Improves Glucose and Lipoprotein Metabolism, and Reduces Diastolic Blood Pressure1

    Article • The Journal of Clinical Endocrinology & Metabolism, March 1997, Endocrine Society

    Professor Gudmundur Johannsson

  256. Diurnal variation in serum insulin-like growth factor (IGF)-I and IGF binding protein-3 concentrations during daily subcutaneous injections of recombinant human growth hormone in GH-deficient adults

    Article • Clinical Endocrinology, January 1997, Wiley

    Professor Gudmundur Johannsson

  257. Long‐term cardiovascular effects of growth hormone treatment in GH‐deficient adults Preliminary data in a small group of patients

    Article • Clinical Endocrinology, September 1996, Wiley

    Professor Gudmundur Johannsson

  258. Comparison of methods to estimate body fat in growth hormone deficient adults

    Article • Clinical Endocrinology, April 1996, Wiley

    Professor Gudmundur Johannsson

  259. The Effects of 2 Years Treatment with Recombinant Human Growth Hormone (rhGH) in Growth Hormone Deficient Adults (GHDA)

    Article • Clinical Pediatric Endocrinology, January 1994, Japanese Society for Pediatric Endocrinology

    Professor Gudmundur Johannsson

  260. Treatment: Hormones

    Article • Wiley

    Professor Gudmundur Johannsson

  261. Impact of gender and age on growth hormone responsiveness

    Article • Cambridge University Press

    Professor Gudmundur Johannsson

  262. Growth Hormone and Syndrome X

    Article • Springer Science + Business Media

    Professor Gudmundur Johannsson